Evidence map›Paper›PMID 36873678›Full record

ReviewJACS Au2023

Chemical RNA Cross-Linking: Mechanisms, Computational Analysis, and Biological Applications.

Willem A Velema, Zhipeng Lu

Abstract readReview
In one paragraph

Review in JACS Au, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Selection-free whole genome transplantation revives dead microbes.bioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Site-Selective Ligand Selection by Mutational Profiling for Covalent RNA Targeting.Angewandte Chemie (International ed. in English) · 2026
    Article
  8. Review
  9. Article
  10. PEI-FeBiosensors · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. mirTarCLASH: a comprehensive miRNA target database based on chimeric read-based experiments.Database : the journal of biological databases and curation · 2025
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Willem A VelemaInstitute for Molecules and Materials, Radboud University, Nijmegen 6500 HC, The Netherlands.ORCID https://orcid.org/0000-0003-0257-2734
Zhipeng LuDepartment of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California 90033, United States.

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
The Southernearch Center for ALPD and CirrhosisP50AA011999 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HIDEKAZU TSUKAMOTO · 1999 to 2026
$45.8M
USC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KAPLOWITZ, NEIL · 1995 to 2020
$21.8M
High Throughput Determination of RNA 3D Structures and Dynamics in VivoR35GM143068 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LU, ZHIPENG · 2021 to 2025
$2.1M
Decoding the RNA Structurome: Method Development and Function Analysis.R00HG009662 · NHGRI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LU, ZHIPENG · 2019 to 2021
$821k
Neurovascular functions of a small RNA Snord118-mediated ribosome biogenesisR21AG075665 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CHEN, JIANFU · 2022 to 2022
$454k
NCI NIH HHS P30 CA014089NHGRI NIH HHS R00 HG009662NIAAA NIH HHS P50 AA011999NIA NIH HHS R21 AG075665NIDDK NIH HHS P30 DK048522NIGMS NIH HHS R35 GM143068
6 · The paper itself

Abstract

In recent years, RNA has emerged as a multifaceted biomolecule that is involved in virtually every function of the cell and is critical for human health. This has led to a substantial increase in research efforts to uncover the many chemical and biological aspects of RNA and target RNA for therapeutic purposes. In particular, analysis of RNA structures and interactions in cells has been critical for understanding their diverse functions and druggability. In the last 5 years, several chemical methods have been developed to achieve this goal, using chemical cross-linking combined with high-throughput sequencing and computational analysis. Applications of these methods resulted in important new insights into RNA functions in a variety of biological contexts. Given the rapid development of new chemical technologies, a thorough perspective on the past and future of this field is provided. In particular, the various RNA cross-linkers and their mechanisms, the computational analysis and challenges, and illustrative examples from recent literature are discussed.

Identifiers

PMID36873678
PMCPMC9975857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.